Novel adamantylated pyrimidines and their preliminary biological evaluations

Farmaco

Volumn 59, Issue 12, 2004, Pages 929-937

  Orzeszko, Barbara ^a   Kazimierczuk, Zygmunt ^b,c   Maurin, Jan Krzysztof ^d,e   Laudy, Agnieszka Ewa ^f   Staróciak, Bohdan Jerzy ^f   Vilpo, Juhani ^g   Vilpo, Leena ^g   Balzarini, Jan ^h   Orzeszko, Andrzej ^b,i  

^a WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b Agricultural University   (Poland)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^d INSTITUTE OF ATOMIC ENERGY   (Poland)

^e NATIONAL MEDICINES INSTITUTE   (Poland)

^f MEDICAL UNIVERSITY OF WARSAW   (Poland)

^g TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^h REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

ⁱ MILITARY UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

6 (Adamantan 1 yl)pyrimidines; Anti HIV; Anticancer and antimicrobial properties

Indexed keywords

3 (ADAMANTAN 1 YL) 3 OXOPROPIONIC ACID ETHYL ESTER; 4 ADAMANTAN 1 YL 2 METHYL 6 [(2 NITROBENZYL)THIO]PYRIMIDINE; 4 ADAMANTAN 1 YL 2 METHYL 6 [(4 NITROBENZYL)THIO]PYRIMIDINE; 6 ADAMANTAN 1 YL 1H PYRIMIDINE 2,4 DIONE; 6 ADAMANTAN 1 YL 1H PYRIMIDINE 2,4 DITHIONE; 6 ADAMANTAN 1 YL 2 [(2 DIMETHYLAMINOETHYL)THIO] 3H PYRIMIDIN 4 ONE; 6 ADAMANTAN 1 YL 2 [(2 NITROBENZYL)THIO] 3H PYRIMIDIN 4 ONE; 6 ADAMANTAN 1 YL 2 [(4 NITROBENZYL)THIO] 3H PYRIMIDIN 4 ONE; 6 ADAMANTAN 1 YL 2 AMINO 3H PYRIMIDIN 4 ONE; 6 ADAMANTAN 1 YL 2 AMINO 5 BROMO 3H PYRIMIDIN 4 ONE; 6 ADAMANTAN 1 YL 2 METHYL 3H PYRIMIDIN 4 ONE; 6 ADAMANTAN 1 YL 2 METHYL 3H PYRIMIDINE 4 THIONE; 6 ADAMANTAN 1 YL 2 THIOXO 2,3 DIHYDRO 1H PYRIMIDIN 4 ONE; 6 ADAMANTAN 1 YL 5 BROMO 1H PYRIMIDINE 2,4 DIONE; [2 (6 ADAMANTAN 1 YL 2 METHYLPYRIMIDIN 4 YL)THIOETHYL]DIMETHYLAMINE; ACETAMIDINE DERIVATIVE; GUANIDINE; PROPIONIC ACID DERIVATIVE; PYRIMIDINE DERIVATIVE; THIOUREA; UNCLASSIFIED DRUG; UREA;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN; X RAY ANALYSIS;

ADAMANTANE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CELL LINE, TUMOR; DRUG EVALUATION, PRECLINICAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES;

EID: 10344247103     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2004.07.010     Document Type: Article

References (24)

1. Davies W.L., Grunert R.R., Haff R.F., McGahen J.W., Neumayer E.M., Paulshock M., Watts J.C., Wood T.R., Hermann T.R., and Hoffmann C.E. Antiviral activity of 1-adamantaneamine Science 144 1964 862 863
2. Thuluvath P.J., Maheshwari A., Mehdi J., Fairbanks K.D., Wu L.L., Gelrud L.G., Ryan M.J., Anania F.A., Lobis I.F., and Black M. Randomised, double blind, placebo controlled trial of interferon, ribavirin amantadine versus interferon, ribavirin, and placebo in treatment naive patients with chronic hepatis C Gut 53 2004 130 135
3. Kolocouris N., Kolocouris A., Fascolos G.B., Fytas G., Neyts J., Padalko E., Balzarini J., Snoeck R., Andrei G., and De Clercq E. Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives 2 J. Med. Chem. 39 1996 3307 3318
4. Evidente V.G.H., Adler C.H., Caviness J.N., and Gwinn-Hardy K. A pilot study on the motor effects of rimantidine in Parkinson's disease Clin. Neuropharmacol. 22 1999 30 32
5. Jain K.K. Evaluation of memantine for neuroprotection in dementia Expert Opin. Invest. Drugs 9 2000 1397 1406
6. Wang J.-J., Wang S.-S., Lee C.-F., Chung M.-A., and Chern Y.-T. In vitro antitumor and antimicrobial activities of N-substotuents of maleimide by adamantane and diamantine Chemotherapy 43 1997 182 189
7. Kazimierczuk Z., Górska A., Świtaj T., and Lasek W. Adamantylaminopyrimidines and pyridines are potent inducers of tumor necrosis factor-alpha Bioorg. Med. Chem. Lett. 11 2001 1197 2000
8. Maurin J.K., Lasek W., Górska A., Świtaj T., Wamil M., Młynarczuk I., and Kazimierczuk Z. Synthesis, structure and tumor necrosis factor production enhancing properties of novel adamantylamino heterocyclic derivatives Anti-Cancer Drug Design 16 2001 73 80
9. Orzeszko A., Lasek W., Świtaj T., Stoksik M., and Kamińska B. Tuor necrosis factor-alpha production-regulating activity of phthalimide derivatives in genetically modified murine melanoma cells B78H1 Farmaco 58 2003 371 376
10. Orzeszko A., Kamińska B., and Starościak B.J. Synthesis and antimicrobial activity of new adamantane derivatives III Farmaco 57 2002 619 624
11. Shokova E., Mousoulou T., Luzikov Y., and Kovalev V. Adamantylation and adamantylalkylation of amides, nitryles and ureas in trifluoroacetic acid Synthesis 1997 1034 1040
12. Kazimierczuk Z., Orzeszko A., and Sikorska A. Kisakurek M.V. Rosemeyer H. Perspectives in Nucleosides and Nucleic Acid Chemistry 2000 Wiley-VCH Weinheim, Germany 87 94
13. Basnak I., Balkan A., Coe P.L., and Walker R.T. The synthesis of some 5-substituted and 5,6-disubstituted 2′-deoxyuridines Nucleosides, Nucleotides 13 1994 177 196
14. 1-allyl-5,6-substituted 2-thiouracil derivatives in mice Chem. Pharm. Bull. 46 1998 1370 1373
15. Stetter H., and Rauscher E. Zur Kenntnis des β-[adamantyl-1]-β- oxo-propionsäure-äthylesters Chem. Ber. 93 1960 2054 2057
16. Johnson T.B., and Hill A.J. Researches on pyrimidines. LXX. The isomerism of 4-phenylisocytosine J. Am. Chem. Soc. 36 1914 1201 1210
17. Brown T.B., and Stevens M.F.G. Triazynes and related products. Part XV J. Chem. Soc. Perkin Trans. 1 1975 1023 1028
18. Orzeszko A., Maurin J.K., and Melon-Ksyta D. Investigation of the thionation reaction of cyclic imides Z. Naturforsch. 56b 2001 1035 1040
19. Cava M.P., and Levinson M.I. Thionation reactions of Lawesson's reagents Tetrahedron 41 1985 5061 5087
20. Sheldrick G.M. SHELXS-97, Program for Determination of Crystal Structures 1997 University of Göttingen
21. Sheldrick G.M. SHELXL-97, Program for Refinement of Crystal Structures 1997 University of Göttingen
22. National Committee for Clinical Laboratory Standards NCCLS Approval Standard Document M2-A7 2000 Villanova, PA, USA.
23. National Committee for Clinical Laboratory Standards NCCLS Approval Standard Document M7-A4 2000 Villanova, PA, USA.
24. Akira S., and Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family Immunol. Lett. 85 2003 85 95